Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 381-390 of 527 for center for individualized medicine

Edit search filters
  1. Diagnostic and Prognostic Validity of Tissue-based Biomarker Assay for Acute Graft-versus-host Disease of the Skin: A Retrospective Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study to Identify Biomarkers in the Blood, Saliva or Tissue for Oropharyngeal Squamous Cell Cancer

    Rochester, MN

  3. Treatment of Multifocal Lung Adenocarcinoma

    Rochester, MN

  4. Validation of a Blood Assay for the Detection of BRAF Mutation Status in Patients with Metastatic Melanoma

    Rochester, MN

  5. A Study of Blood Clotting Response in Patients with a Traumatic Injury

    Rochester, MN

  6. Mutational Analysis of Alternative Pathway Complement Regulatory Proteins

    Rochester, MN

  7. A Study to Develop a Biobank of Samples from Patients Undergoing Therapy with PCSK9 Inhibitors

    Rochester, MN

  8. A Study of Clinical Symptoms in PMM2 Patients Affected by mtDNA Variants and Haplotypes

    Rochester, MN

  9. Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary Cancer and Changes in Gut Microbiome

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study to Evaluate the Role of Mitochondrial DNA in Encoding Histocompatibility Antigens in Humans and Rejection in Heart and Lung Transplant

    Jacksonville, FL

.

Mayo Clinic Footer